Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
489
-
Total 13F shares, excl. options
-
19M
-
Shares change
-
+5.49K
-
Total reported value, excl. options
-
$9.09B
-
Value change
-
+$18.9M
-
Put/Call ratio
-
0.97
-
Number of buys
-
260
-
Number of sells
-
-189
-
Price
-
$479.02
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q1 2023
547 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q1 2023.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 489 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (2.4M shares), BlackRock Inc. (1.6M shares), Veritas Asset Management LLP (1.15M shares), STATE STREET CORP (922K shares), BROWN ADVISORY INC (846K shares), ALLIANCEBERNSTEIN L.P. (544K shares), UBS ASSET MANAGEMENT AMERICAS INC (534K shares), BANK OF AMERICA CORP /DE/ (460K shares), MILLENNIUM MANAGEMENT LLC (457K shares), and GEODE CAPITAL MANAGEMENT, LLC (445K shares).
This table shows the top 489 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.